三维适形放疗与调强放疗治疗原发性肝癌伴门静脉癌栓的剂量学比较

周媛媛; 张思杏; 郑青平; 石成良; 罗展雄; 李旌; 于斌; 李中华

doi:10.3969/j.issn.1001-5256.2014.03.012

三维适形放疗与调强放疗治疗原发性肝癌伴门静脉癌栓的剂量学比较

DOI: 10.3969/j.issn.1001-5256.2014.03.012

柳州市人民医院肿瘤放疗科

基金项目:

广西壮族自治区卫生厅自筹经费课题(Z2011294)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 3009
- HTML全文浏览量: 17
- PDF下载量: 596
- 被引次数: 0
出版历程
- 出版日期: 2014-03-20

Dosimetric comparison of 3DCRT and IMRT in treatment of primary hepatocellular carcinoma with portal vein tumor thrombus

Research funding:

摘要

摘要:
目的评估三维适形放疗(3DCRT)与调强放疗(IMRT)2种不同放疗技术在原发性肝癌伴门静脉癌栓放射治疗中的优缺点。方法 20例不能手术的原发性肝癌并门静脉癌栓的患者分别进行3DCRT和IMRT 2种放疗计划设计,处方剂量均为40 Gy/20 f。比较2组计划的靶区与危及器官剂量学参数及加速器跳数(MU)。2组间比较采用t检验。结果 IMRT在计划靶体积(PTV)的剂量覆盖、均一性及适形度均优于3DCRT(P<0.05);3DCRT与IMRT的肝V30 Gy及肝V20 Gy分别为33.55±5.67vs 29.41±2.67(P=0.001)和44.24±6.17 vs 41.28±4.59(P=0.021)。2组的正常肝组织低剂量区范围与胃、小肠、脊髓、双肾的受照射剂量并无显著性差异。3DCRT与IMRT的MU分别为303.7±35.8和377.4±33.2(P=0.000)。结论与3DCRT相比,IMRT有较满意的PTV高剂量覆盖及均匀的剂量分布。在危及器官保护方面,IMRT的肝脏高剂量区范围明显低于3DCRT,而不足的是,IMRT的治疗时间显著长于3DCRT。
- 肝肿瘤 /
- 放射疗法,适形 /
- 放射疗法,调强适形 /
- 放射治疗剂量
Abstract:
Objective To compare three- dimensional conformal radiotherapy ( 3DCRT) and intensity- modulated radiotherapy ( IMRT) in terms of their advantages of disadvantages in the treatment of primary hepatocellular carcinoma ( PHC) with portal vein tumor thrombus ( PVTT) . Methods Twenty patients with PHC accompanied by PVTT were enrolled in this study. Each patient underwent 3DCRT and IMRT with a prescribed dose of 40 Gy / 20 fractions. The parameters included the conformity index ( CI) , homogeneity index ( HI) , mean dose ( Dmean) , minimum dose ( Dmin) , maximum dose ( Dmax) , V95%, V100%, and V105% for planning target volume ( PTV) , the number of monitor units ( MUs) for evaluating planning efficiency, and Dmean, Dmax, and Dmin for the organs at risk ( OAR) . The percentage of the normal liver volume receiving ≥30, > 20, > 10, and > 5 Gy ( V30 Gy, V20 Gy, V10 Gy, and V5 Gy, respectively) were calculated to determine liver toxicity. The two radiotherapy regimens were compared in terms of the dosimetric parameters for PTV and OAR, as well as number of MUs. Results IMRT had significantly higher Dmin, Dmean, V95%, and V100% and significantly better HI and CI compared with 3DCRT ( P < 0. 05) . The liver V30 Gy and V20 Gy were 33. 55 ± 5. 67 and 44. 24 ± 6. 17, respectively, for 3DCRT, versus 29. 41 ± 2. 67 and 41. 28 ± 4. 59 for IMRT ( P = 0. 001; P = 0. 021) . There were no significant differences in liver V10 Gy, liver V5 Gy, stomach Dmax, small intestine Dmax, spinal cord Dmax, kidney Dmax, and kidney V20 Gy between IMRT and 3DCRT. The number of MUs was 303. 7 ± 35. 8 for 3DCRT and 377. 4 ± 33. 2 for IMRT ( P = 0. 000) . Conclusion IMRT provides higher tumor coverage, homogeneity, and conformity, as well as better normal liver tissue sparing, as compared with 3DCRT. However, IMRT is not superior to 3DCRT in terms of treatment efficiency.
- liver neoplasms /
- radiotherapy, confarmal /
- radiotherapy, intensity-modulated /
- radiotherapy dosage

HTML全文

参考文献(11)

[1]YOVINO S, POPPE M, JABBOUR S, et al.Inensity-modulated radiation therapy significantly improve acute gastrointestinal toxicity in pancreatic and ampullary cancers[J].Int J Radiat Oncol Biol Phys, 2011, 79 (1) :158-162.

[2]MURTHY K, SHUKEILI K, KUMAR S, et al.Evaluation of dose coverage to target volume and normal tissue sparing in the adjuvant radiotherapy of gastric cancers:3D-CRT compared with dynamic IMRT[J].Biomed Imaging Interv J, 2010, 6 (3) :e29.

[3]WEISS E, SIEBERS JV, KEALL PJ.An analysis of 6MV versus18MV photon energy plans for intensity-modulated radiation therapy (IMRT) of lung cancer[J].Radiather Oncol, 2007, 82 (1) :55-62.

[4]HU WG, ZHANG Z, XU ZY, et al.Comparison of dosimtry between three-dimension conformal and intensity modulated plan in postoperative for gastric cancer[J].Chin J Radiat Oncol, 2007, 16 (4) :273-276. (in Chinese) 胡伟刚, 章真, 徐志勇, 等.三维适形放疗与调强放疗技术在胃癌术后放疗中的剂量学比较[J].中华放射肿瘤学杂志, 2007, 16 (4) :273-276.

[5]WHANG-PENG J, CHENG AL, HSU C, et al.Clinical development and future direction for the treatment of hepatocellular carcinoma[J].J Exp Clin Med, 2010, 2 (3) :93-103.

[6]KE CQ, PENG EL.Non-surgical treatment of primary liver cancer[J].China Med Herald, 2013, 10 (14) :32-35. (in Chinese) 柯传庆, 彭恩兰.原发性肝癌的非手术治疗[J].中国医药导报, 2013, 10 (14) :32-35.

[7]YAMADA K, IZAKI K, SUGIMOTO K, et al.Prospective trial of combinied transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys, 2003, 57 (1) :113-119.

[8]SHUENG PW, LIN SC, CHANG HT, et al.Toxicity risk of nontarget organs at risk receiving low-dose radiation:case report[J].Radiat Oncol, 2009, 31 (4) :71.

[9]YAMASHITA H, NAKAGAWA K, NAKAMURA N, et al.Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors[J].Radiat Oncol, 2007, 7 (2) :21.

[10]XU ZY, LIANG SX, ZHU J, et al.Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma[J].Int J Radiat Oncol Biol Phys, 2006, 65 (1) :189-195.

[11]KAMPINGA HH, HIEMSTRA YS, KONINGS AW, et al.Correlation between slowly repairable double-strand breaks and thermal radiosensitizationi in the human Hela S3 cell line[J].Int J Radiat Biol, 1997, 72:293-301.

施引文献

资源附件(0)

访问统计